Jenburkt Pharmaceuticals Share Price
JENBURPH
Live Jenburkt Pharmaceuticals Share Price Chart
Jenburkt Pharmaceuticals Performance
Days Range
| Previous Close | ₹1,045.50 |
|---|---|
| Open | ₹1,042.7 |
| Volume | 1,103 |
| Day's Range | ₹1,027.00 - ₹1,048.00 |
|---|---|
| 52W Range | ₹1,027.00 - ₹1,073.90 |
| Market Cap | ₹456.51 Cr |
Jenburkt Pharmaceuticals Fundamentals
| ROCE(TTM) | 23.20 |
|---|---|
| P/E Ratio (TTM) | 13.91 |
| P/B Ratio | 2.32 |
| Industry P/E | 50.37 |
| Debt to Equity | 0.01 |
| ROE | 17.63 |
| EPS (TTM) | 80.96 |
| Dividend Yield | 2 |
| Book Value | 446.47 |
| Face Value | 10 |
| ROCE(TTM) | 23.20 |
|---|---|
| P/E Ratio (TTM) | 13.91 |
| P/B Ratio | 2.32 |
| Industry P/E | 50.37 |
| Debt to Equity | 0.01 |
| ROE | 17.63 |
|---|---|
| EPS (TTM) | 80.96 |
| Dividend Yield | 2 |
| Book Value | 446.47 |
| Face Value | 10 |
Jenburkt Pharmaceuticals Financials
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Net Sales | 45.56 | 43.02 | 44.63 | 35.51 |
| Expenses | 33.20 | 36.43 | 31.19 | 30.13 |
| Profit before tax | 14.33 | 8.30 | 13.71 | 6.77 |
| Operating Profit | 10.16 | 5.93 | 10.85 | 5.89 |
| Net Profit | 10.16 | 5.93 | 10.85 | 5.89 |
| EPS in Rs | 23.03 | 13.44 | 33.53 | 13.34 |
Jenburkt Pharmaceuticals Shareholding Pattern
Promoters
46.62%
Retail And Others
53.26%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.12%
About Jenburkt Pharmaceuticals
Jenburkt Pharmaceuticals Ltd., a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family, was formed in 1985.Jenburkt is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.
Jenburkt is a public limited company, with its stock listed on the Bombay Stock Exchange.Jenburkt`s head quarters is located in Mumbai, from where its entire operations are handled.
Parent Organisation
Indian Private
Managing Director
Ashish U Bhuta
Founded
1985
NSE Symbol
JENBURPH
Top Mutual Funds Invested in Jenburkt Pharmaceuticals Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,902.4 -1.60 (-0.08%) | ₹4,56,089.58 | 1,548.0 - 2,046.9 |
| Divis Laboratories Ltd | 8,597.0 27.00 (0.32%) | ₹2,26,975.64 | 5,636.5 - 8,674.0 |
| Torrent Pharmaceuticals Ltd | 4,896.5 -108.50 (-2.17%) | ₹1,85,638.53 | 3,480.6 - 5,250.0 |
| Cipla Ltd | 1,432.2 -5.80 (-0.40%) | ₹1,15,216.02 | 1,165.7 - 1,673.0 |
| Zydus Lifesciences Ltd | 1,120.0 12.30 (1.11%) | ₹1,11,720.43 | 835.5 - 1,205.0 |
| Lupin Ltd | 2,201.8 0.30 (0.01%) | ₹1,00,271.10 | 1,875.0 - 2,529.5 |
Popular Stocks
Jenburkt Pharmaceuticals Ltd FAQs
Can I buy Jenburkt Pharmaceuticals Ltd (JENBURPH) from Angel One?
Yes, You can buy Jenburkt Pharmaceuticals Ltd (JENBURPH) shares by opening a Demat account with Angel One.
How do I buy Jenburkt Pharmaceuticals Ltd (JENBURPH) from Angel One?
Jenburkt Pharmaceuticals Ltd (JENBURPH) share can be bought through the following modes:
1. Direct investment: You can buy Jenburkt Pharmaceuticals Ltd (JENBURPH) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Jenburkt Pharmaceuticals Ltd (JENBURPH) shares.
1. Direct investment: You can buy Jenburkt Pharmaceuticals Ltd (JENBURPH) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Jenburkt Pharmaceuticals Ltd (JENBURPH) shares.
